Improvement of the anticancer activity of bozepinib, bozinib and derivatives, through the introduction of the trifluoromethyl group
UGR001 / A-03 / PI
Year of the call
2016
Execution date
01/01/2017 - 31/12/2018
UGR001 / A-03 / PI
2016
01/01/2017 - 31/12/2018